Participant 1 carries the heterozygous PLCG2 gene mutation p.Ala708Pro (Fig. 3b) and presented with cutaneous lesions at disease onset and mild hypogammaglobulinemia followed by recurrent infections at later stages. The gene discussed is PLCG2; the disease is infection.